Actively Recruiting
Evaluation of the Therapeutic Approach of Aromatherapy by Olfaction of Essential Oils in Association With Hypnosis in the Management of Patients Followed for Cancer
Led by Centre Hospitalier Intercommunal Creteil · Updated on 2026-03-11
66
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Patients having the following gestures (blood test, change of dressing for cancerous lesion and complete toilet in bed) will be identified by the team of the medical oncology department. During the first contact (V0), the study will be presented to the patients in order to obtain their consent. Anxiety and well-being will be assessed before performing the gesture causing discomfort (gesture No.1). The gesture will then be performed and the patient's comfort will be evaluated after the gesture is performed in order to obtain the starting data for the study. Patients will be reviewed in consultation according to the time recommended for each type of gesture. During the second contact V1 (between 1 and 9 days after D0) anxiety and well-being will be assessed before performing the gesture causing discomfort (gesture No.2). Patients will then be randomized. After randomization, the first hypnosis session will be performed at the same time as gesture No. 2 and the patient's comfort will be evaluated after the gesture is performed. The patient will receive the self-hypnosis training on the same day. A period of 7 ± 2 days will be considered for the learning time of self-hypnosis. The third contact will take place on day D7+/-2 after V1. During this visit, anxiety and well-being will be assessed before performing the gesture causing discomfort (gesture No.3). Gesture No.3 will be carried out under the effect of self-hypnosis ± aromatherapy and the measurement of comfort will be carried out immediately afterwards
CONDITIONS
Official Title
Evaluation of the Therapeutic Approach of Aromatherapy by Olfaction of Essential Oils in Association With Hypnosis in the Management of Patients Followed for Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 65 18 years
- Patients followed in medical oncology and by the mobile palliative care support team
- Patients starting first line chemotherapy
- Patients requiring at least one of these procedures: blood samples via central catheter with Huber needle, peripheral venous samples, change of dressing for cancerous lesion, or complete toilet in bed
- Patients who have given their consent
- Patients affiliated with a social security scheme
You will not qualify if you...
- Patients under guardianship or curatorship
- Persons deprived of liberty
- Persons unable to express consent
- Pregnant or breastfeeding women
- History of allergy or intolerance to essential oils
- Patients with cognitive or language disorders preventing questionnaire responses
- Patients with psychotic disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Hospitalier Intercommunal de Créteil
Créteil, France, 94000
Actively Recruiting
Research Team
L
Lambert VADROT
CONTACT
C
Camille JUNG
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here